E Walmsley

This profile gathers the share dealings of E Walmsley in GlaxoSmithKline plc. In total, 162 filings cover trades dated from 11 July 2016 to 12 May 2021.

In open-market terms, that means 10 purchases worth €2,913 on one side and 3 sales worth €3.5M on the other. Taken together, the sales exceed the purchases by €3.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 144 share grants. 2021 to date brings no purchases and 1 sale.

The median purchase comes to €302. 10 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 13 May 2021 with a share grant (€312) in GlaxoSmithKline plc. The last insider purchase was made public on 11 May 2017, 3,467 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.